Communicating NIH Support and Impact

https://www.niams.nih.gov/about/about-the-director/letter/communicating-nih-support-and-impact

Dear Colleagues: Did you know that 95 percent of the NIH budget goes directly to research awards, programs, and centers; training programs; and research and development contracts? NIH-supported research leads to tens of thousands of new scientific findings every year. At NIAMS, we are proud to be funding exceptional science on bone, muscle, joint and skin diseases, and we ask for your support to help us spread the word about these exciting projects. Earlier this month, NIAMS grantees received our biannual reminder that press releases, videos, publications, interviews with reporters, and other communications must include acknowledgment of NIH support. We

Study Suggests Most Women With Mild to Moderate Lupus Can Expect to Have Healthy Pregnancies

https://www.niams.nih.gov/newsroom/spotlight-on-research/study-suggests-most-women

A large, long-term study among women with lupus has yielded important insights into how to predict who may develop pregnancy complications associated with the disease, and who is most likely to have a healthy pregnancy. A related study identified key factors that may put a woman at risk for problems, allowing for early detection and monitoring.

Two Drugs That Treat Rheumatoid Arthritis and Blood Cancers Shown to Promote Hair Growth

https://www.niams.nih.gov/newsroom/spotlight-on-research/two-drugs-that-treat-rheumatoid

Two drugs—one used to treat rheumatoid arthritis and another for different types of blood cancers—have shown promise in reversing hair loss characteristic of alopecia areata and related disorders, according to a study in mice funded in part by the NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The study was published in Science Advances.

At NIH, Minority Health Is Everyone’s Concern, Every Day

https://www.niams.nih.gov/about/about-the-director/letter/nih-minority-health-everyones-concern-every-day

Eliseo J. Pérez-Stable, M.D. is Director of the National Institute on Minority Health and Health Disparities at the NIH. He oversees the Institute’s $281 million budget to conduct and support research, training, and information dissemination programs to improve minority health and reduce health disparities. Dear Colleagues: April is National Minority Health Month , an observance that is my life’s work and the foundation of our work at the National Institute on Minority Health and Health Disparities (NIMHD) . The mission of NIMHD is to lead scientific research that will improve minority health, reduce health disparities, and promote health equity. We

Enhancing Support for Early-Career Stage Clinician Scientists

https://www.niams.nih.gov/about/about-the-director/enhancing-support-early-career-stage

Dear Colleagues: As Director of the NIAMS, one of my most important responsibilities is to foster the next generation of biomedical researchers. Over the past several years, the NIH and the NIAMS have taken a number of steps to support early-stage investigators, notably clinician scientists, who face unique challenges in pursuing research careers. I discussed some of those efforts, including the NIH K08 and K23 Career Development Awards for clinician scientists and the NIH Loan Repayment Programs , in a Director’s letter last summer. Staff across the NIAMS have worked diligently to strengthen the pipeline of clinician scientists through sustained

Dog with Duchenne Muscular Dystrophy Escapes the Disease, Spurring Interest in Potential New Treatment Approach

https://www.niams.nih.gov/newsroom/spotlight-on-research/dog-with-duchenne-muscular-dystrophy

A golden retriever carrying the gene mutation for Duchenne muscular dystrophy (DMD) unexpectedly remained healthy for life, sparking interest in a new avenue of investigation into DMD treatment. The study, which was published in the journal Cell and supported in part by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), revealed that a gene not known to be linked to DMD may hold promise for counteracting the effects of the muscle wasting disease.

Building Bridges to Enhance Patient Care: The NIAMS Intramural Research Program

https://www.niams.nih.gov/about/about-the-director/letter/building-bridges-enhance-patient-care

The NIAMS Intramural Research Program (IRP), and the entire intramural program at NIH, offer unique resources in the biomedical research enterprise. The long-term, high-risk, high-reward focus of the IRP allows researchers to stretch the boundaries of innovation. They are able to build bridges across the traditional silos that tend to separate organizations, patients and scientists, and research results and clinical practice. These collaborations make an enormous difference for all Americans.

NIAMS advisory council welcomes four new members

https://www.niams.nih.gov/newsroom/press-releases/niams-advisory-council-welcomes-four-members

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, has appointed four new members to its advisory council. The council comprises scientific and lay members who have expertise in the mission areas of the institute. Council members provide advice to the institute on broad policy issues, and make recommendations on research proposals.
Subscribe to